Atlas Trials

Everolimus-Eluting Bioresorbable Scaffolds Versus Everolimus-Eluting Metallic Stents for Diffuse Long Coronary Artery Disease

Clinical trial NCT02831205 · TERMINATED

Trial details

NCT number
NCT02831205
Sponsor
Duk-Woo Park, MD
Status
TERMINATED
Phase
Phase 4
Study type
INTERVENTIONAL
Percutaneous Transluminal Coronary Angioplasty
Start date
2016-07-01
Primary completion
2017-12-01
Enrollment
800

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.